Cargando…
Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071895/ https://www.ncbi.nlm.nih.gov/pubmed/36927258 http://dx.doi.org/10.1080/22221751.2023.2192817 |
| _version_ | 1785019279912992768 |
|---|---|
| author | Liu, Zezhong Lu, Lu Jiang, Shibo |
| author_facet | Liu, Zezhong Lu, Lu Jiang, Shibo |
| author_sort | Liu, Zezhong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10071895 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100718952023-04-05 Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines Liu, Zezhong Lu, Lu Jiang, Shibo Emerg Microbes Infect Coronaviruses Taylor & Francis 2023-04-03 /pmc/articles/PMC10071895/ /pubmed/36927258 http://dx.doi.org/10.1080/22221751.2023.2192817 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| spellingShingle | Coronaviruses Liu, Zezhong Lu, Lu Jiang, Shibo Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title | Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title_full | Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title_fullStr | Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title_full_unstemmed | Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title_short | Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines |
| title_sort | application of “b+1” heterologous boosting strategy for preventing infection of sars-cov-2 variants with resistance to broad-spectrum coronavirus vaccines |
| topic | Coronaviruses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071895/ https://www.ncbi.nlm.nih.gov/pubmed/36927258 http://dx.doi.org/10.1080/22221751.2023.2192817 |
| work_keys_str_mv | AT liuzezhong applicationofb1heterologousboostingstrategyforpreventinginfectionofsarscov2variantswithresistancetobroadspectrumcoronavirusvaccines AT lulu applicationofb1heterologousboostingstrategyforpreventinginfectionofsarscov2variantswithresistancetobroadspectrumcoronavirusvaccines AT jiangshibo applicationofb1heterologousboostingstrategyforpreventinginfectionofsarscov2variantswithresistancetobroadspectrumcoronavirusvaccines |